The reduction of endogenous antioxidants in ALD and NAFLD may enhance CYP2E1-induced lipid peroxidation, oxidant stress and cellular toxicity. The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatotic liver disease.